Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod

Detalles Bibliográficos
Autores principales: Senzaki, Kensuke, Ochi, Hirofumi, Ochi, Masayuki, Okada, Yoko, Miura, Shiroh, Ohyagi, Yasumasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142249/
https://www.ncbi.nlm.nih.gov/pubmed/34041374
http://dx.doi.org/10.1016/j.ensci.2021.100346
_version_ 1783696512501415936
author Senzaki, Kensuke
Ochi, Hirofumi
Ochi, Masayuki
Okada, Yoko
Miura, Shiroh
Ohyagi, Yasumasa
author_facet Senzaki, Kensuke
Ochi, Hirofumi
Ochi, Masayuki
Okada, Yoko
Miura, Shiroh
Ohyagi, Yasumasa
author_sort Senzaki, Kensuke
collection PubMed
description
format Online
Article
Text
id pubmed-8142249
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81422492021-05-25 Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod Senzaki, Kensuke Ochi, Hirofumi Ochi, Masayuki Okada, Yoko Miura, Shiroh Ohyagi, Yasumasa eNeurologicalSci Letter to the Editor Elsevier 2021-05-15 /pmc/articles/PMC8142249/ /pubmed/34041374 http://dx.doi.org/10.1016/j.ensci.2021.100346 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Senzaki, Kensuke
Ochi, Hirofumi
Ochi, Masayuki
Okada, Yoko
Miura, Shiroh
Ohyagi, Yasumasa
Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
title Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
title_full Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
title_fullStr Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
title_full_unstemmed Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
title_short Disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
title_sort disease reactivation in a patient with secondary progressive multiple sclerosis after switching treatment from fingolimod to siponimod
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142249/
https://www.ncbi.nlm.nih.gov/pubmed/34041374
http://dx.doi.org/10.1016/j.ensci.2021.100346
work_keys_str_mv AT senzakikensuke diseasereactivationinapatientwithsecondaryprogressivemultiplesclerosisafterswitchingtreatmentfromfingolimodtosiponimod
AT ochihirofumi diseasereactivationinapatientwithsecondaryprogressivemultiplesclerosisafterswitchingtreatmentfromfingolimodtosiponimod
AT ochimasayuki diseasereactivationinapatientwithsecondaryprogressivemultiplesclerosisafterswitchingtreatmentfromfingolimodtosiponimod
AT okadayoko diseasereactivationinapatientwithsecondaryprogressivemultiplesclerosisafterswitchingtreatmentfromfingolimodtosiponimod
AT miurashiroh diseasereactivationinapatientwithsecondaryprogressivemultiplesclerosisafterswitchingtreatmentfromfingolimodtosiponimod
AT ohyagiyasumasa diseasereactivationinapatientwithsecondaryprogressivemultiplesclerosisafterswitchingtreatmentfromfingolimodtosiponimod

Ejemplares similares